SMAC mimetics sensitize HIV-infected cells to oncolytic virus-mediated death. [PDF]
Molyer B, Ameeriar Y, Angel JB.
europepmc +1 more source
Oncolytic virus therapy in the elderly: immune frailty, challenges, and perspectives. [PDF]
Wang JW +4 more
europepmc +1 more source
Oncolytic virus therapy for hepatocellular carcinoma: A bibliometric analysis of research landscapes, hotspots, and clinical transformation trends from 2000 to mid-2025. [PDF]
Yu F, Yin S, Zhu J, Sun K.
europepmc +1 more source
Analysis of oncolytic adenovirus dl922-947 effects on anaplastic thyroid carcinoma cells (ATC) and potential therapeutic associations [PDF]
Iacuzzo, Irma
core
Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma. [PDF]
Ageenko A +10 more
europepmc +1 more source
Cancer genetics and response to oncolytic virus treatment for ovarian cancer. [PDF]
Fletcher EL, Cudmore AO, Vanderhyden BC.
europepmc +1 more source
Mechanisms of Oncolytic Virus-Induced Multi-Modal Cell Death and Therapeutic Prospects. [PDF]
Xu J, Liu C, An Y, Sun J, Wang S, Xia Q.
europepmc +1 more source
Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1<sup>+</sup>CD8<sup>+</sup> T cells. [PDF]
Lin X +13 more
europepmc +1 more source
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1. [PDF]
Hu L +20 more
europepmc +1 more source
A Multi-Omics Dataset of Prostate Cancer Response to Oncolytic Virus OH2 Treatment. [PDF]
Xu J +6 more
europepmc +1 more source

